Proxy Votes Now

Home › Funds › BlackRock › iShares Global Healthcare ETF

iShares Global Healthcare ETF (IXJ) proxy voting record 2025-2026

Fund family: BlackRock · Filed by iSHARES TRUST (CIK 1100663) · SEC series S000004372

Ticker: IXJ (C000012102)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 1,558 with, 36 against, 19 abstentions (not counted as with management); 19 items carried no recommendation. Shareholder proposals: 2 FOR, 33 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with BlackRock as a whole

The same two figures as BlackRock’s manager page (1,606,521 ballot items across 392 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsBlackRockItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)96.2%1,40793.6%1,355,861
Backed environmental and social shareholder proposals at US companiesn/a65.5%6,306

Where this fund voted differently from most BlackRock funds

Each ballot item this fund voted is set against the votes of the other BlackRock funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most BlackRock funds on 1 item (0.1% of the 1,623 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost BlackRock fundsMgmtResult
COLOPLAST A/S2025-12-04AMEND REMUNERATION POLICYAgainstFOR — 26 of 37 BlackRock fundsAgainst—

Download all 1 differences (CSV)

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections9911
Corporate Governance17418
Say-on-Pay1240
Capital Structure1070
Audit-related1050
Compensation822
Shareholder Rights and Defenses299
Other Social Issues164
Extraordinary Transactions40
Human Rights or Human Capital/workforce22

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
ELI LILLY AND COMPANYMay 4, 2026$577M102
JOHNSON & JOHNSONApril 23, 2026$346M151
ABBVIE INC.May 8, 2026$252M81
UNITEDHEALTH GROUP INCORPORATEDJune 1, 2026$179M121
MERCK & CO., INC.May 26, 2026$172M183
THERMO FISHER SCIENTIFIC INC.May 20, 2026$125M130
AMGEN INC.May 19, 2026$121M151
GILEAD SCIENCES, INC.April 30, 2026$105M153

Notable votes against management

MeetingCompanyProposalFundMgmt
May 4, 2026ELI LILLY AND COMPANYShareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposalAgainstFor
May 4, 2026ELI LILLY AND COMPANYShareholder proposal to prepare an annual lobbying report. Shareholder proposalAgainstFor
April 23, 2026JOHNSON & JOHNSONIndependent Board Chair Shareholder proposalAgainstFor
May 8, 2026ABBVIE INC.Stockholder Proposal - to Adopt a Policy to Require an Independent Chair Shareholder proposalAgainstFor
June 1, 2026UNITEDHEALTH GROUP INCORPORATEDIf properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. Shareholder proposalAgainstFor
May 26, 2026MERCK & CO., INC.Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposalAgainstFor
May 26, 2026MERCK & CO., INC.Shareholder proposal regarding a report on healthcare coverage gaps. Shareholder proposalAgainstFor
May 19, 2026AMGEN INC.Stockholder proposal to require an independent board chairman. Shareholder proposalAgainstFor
April 30, 2026GILEAD SCIENCES, INC.To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting. Shareholder proposalAgainstFor
April 30, 2026GILEAD SCIENCES, INC.To vote on a stockholder proposal requesting a report on the impact of extended patent exclusivities on patient access, if properly presented at the Annual Meeting. Shareholder proposalAgainstFor
April 23, 2026PFIZER INC.Adopt an Independent Chair Policy Shareholder proposalAgainstFor
May 13, 2026VERTEX PHARMACEUTICALS INCORPORATEDShareholder Proposal, if properly presented at the meeting, regarding shareholder right to act by written consent. Shareholder proposalAgainstFor

Search this fund’s votes by company

1,634 ballot items at 118 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, iShares Global Healthcare ETF (IXJ) voted at 118 shareholder meetings of 112 companies, on 1,634 ballot items in all. Where management made a recommendation, the fund followed it on 96.6% of the items and voted against it 36 times. Its most frequent area of disagreement was corporate governance (18 of its votes against management). It voted on 35 shareholder proposals. It voted FOR the board's own proposals more often than BlackRock's funds as a whole (96.2% against 93.6%). It voted differently from most BlackRock funds on 1 item.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of BlackRock’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.